Group One Trading’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-547
| Closed | -$798 | – | 8101 |
|
|
2025
Q3 | $875 | Hold |
547
| – | – | ﹤0.01% | 8076 |
|
|
2025
Q2 | $766 | Buy |
+547
| New | +$819 | ﹤0.01% | 7607 |
|
|
2024
Q2 | – | Sell |
-22,559
| Closed | -$186K | – | 6689 |
|
|
2024
Q1 | $177K | Buy |
22,559
+17,519
| +348% | +$113K | ﹤0.01% | 3671 |
|
|
2023
Q4 | $25.6K | Buy |
+5,040
| New | +$26K | ﹤0.01% | 5559 |
|
|
2023
Q3 | – | Sell |
-15,413
| Closed | -$103K | – | 7626 |
|
|
2023
Q2 | $114K | Sell |
15,413
-24,256
| -61% | -$206K | ﹤0.01% | 4484 |
|
|
2023
Q1 | $375K | Buy |
39,669
+37,657
| +1,872% | +$397K | ﹤0.01% | 3032 |
|
|
2022
Q4 | $21.4K | Sell |
2,012
-70,244
| -97% | -$713K | ﹤0.01% | 5561 |
|
|
2022
Q3 | $533K | Buy |
72,256
+27,785
| +62% | +$173K | ﹤0.01% | 3167 |
|
|
2022
Q2 | $214K | Buy |
44,471
+31,864
| +253% | +$181K | ﹤0.01% | 4242 |
|
|
2022
Q1 | $64K | Buy |
12,607
+11,544
| +1,086% | +$60.8K | ﹤0.01% | 5907 |
|
|
2021
Q4 | $6K | Buy |
+1,063
| New | +$7.97K | ﹤0.01% | 7562 |
|
|
2021
Q2 | – | Sell |
-4,385
| Closed | -$34.4K | – | 8118 |
|
|
2021
Q1 | $33K | Sell |
4,385
-27,879
| -86% | -$237K | ﹤0.01% | 6481 |
|
|
2020
Q4 | $252K | Buy |
32,264
+29,553
| +1,090% | +$321K | ﹤0.01% | 3886 |
|
|
2020
Q3 | $26K | Buy |
+2,711
| New | +$29.9K | ﹤0.01% | 5004 |
|
|
2017
Q3 | – | Sell |
-602
| Closed | -$22K | – | 4799 |
|
|
2017
Q2 | $22K | Hold |
602
| – | – | ﹤0.01% | 3909 |
|
|
2017
Q1 | $27K | Buy |
602
+167
| +38% | +$6.41K | ﹤0.01% | 3740 |
|
|
2016
Q4 | $11K | Hold |
435
| – | – | ﹤0.01% | 3907 |
|
|
2016
Q3 | $18K | Buy |
435
+333
| +326% | +$17.1K | ﹤0.01% | 3826 |
|
|
2016
Q2 | $5K | Buy |
102
+70
| +219% | +$3.91K | ﹤0.01% | 4259 |
|
|
2016
Q1 | $2K | Sell |
32
-243
| -88% | -$15.3K | ﹤0.01% | 4361 |
|
|
2015
Q4 | $27K | Sell |
275
-51
| -16% | -$3.39K | ﹤0.01% | 3756 |
|
|
2015
Q3 | $17K | Buy |
326
+209
| +179% | +$14K | ﹤0.01% | 4102 |
|
|
2015
Q2 | $9K | Buy |
117
+30
| +34% | +$2.56K | ﹤0.01% | 4321 |
|
|
2015
Q1 | $6K | Sell |
87
-63
| -42% | -$7.49K | ﹤0.01% | 4296 |
|
|
2014
Q4 | $27K | Buy |
+150
| New | +$28.5K | ﹤0.01% | 3783 |
|
Other funds holding ATNM
VCM
GS
VFT
Group One Trading's ATNM Position: Q4 2025 in Review
Group One Trading sold out of Actinium Pharmaceuticals (ATNM) in Q4 2025, closing a stake of 547 shares — an estimated $798 sold.
Group One Trading first reported a position in ATNM in Q4 2014 and held it in 25 quarters. The position peaked at $533K in Q3 2022. 60 funds tracked by Wall St. Rank hold ATNM as of Q4 2025.
- Group One Trading reported no remaining Actinium Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 547 Actinium Pharmaceuticals shares in Q4 2025, an estimated $798.
- Group One Trading first reported a position in Actinium Pharmaceuticals in Q4 2014 and held it in 25 quarters.
- Group One Trading's Actinium Pharmaceuticals position peaked at $533K in Q3 2022.
- 60 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.